Publication:
Recent advances in human flavivirus vaccines

Simple item page
dc.contributor.authorIris Scherwitzlen_US
dc.contributor.authorJuthathip Mongkolsapajaen_US
dc.contributor.authorGavin Screatonen_US
dc.contributor.otherImperial College Londonen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-12-21T08:00:11Z
dc.date.accessioned2019-03-14T08:03:50Z
dc.date.available2018-12-21T08:00:11Z
dc.date.available2019-03-14T08:03:50Z
dc.date.issued2017-04-01en_US
dc.description.abstract© 2017 Elsevier B.V. Dengue (DENV), West Nile (WNV) and Zika (ZIKV) viruses are mosquito-transmitted flaviviruses that cause thousands of human deaths and millions of illnesses each year. In the last decades, epidemic outbreaks of all three flaviviruses emerged and caused a major health and economical problem in many parts of the world. The increasing and expanding burden of flaviviruses has highlighted the need for effective human vaccines against all three viruses. This review provides an overview of the recent progress in DENV, WNV and ZIKV vaccines development with specific focus on candidates in human clinical development.en_US
dc.identifier.citationCurrent Opinion in Virology. Vol.23, (2017), 95-101en_US
dc.identifier.doi10.1016/j.coviro.2017.04.002en_US
dc.identifier.issn18796265en_US
dc.identifier.issn18796257en_US
dc.identifier.other2-s2.0-85018752101en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/42803
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85018752101&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.titleRecent advances in human flavivirus vaccinesen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85018752101&origin=inwarden_US

Files

Collections

Scopus 2016-2017